Related Experiment Video

Updated: Dec 6, 2025

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
07:27

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Published on: October 6, 2016

10.5K

The outcome of COVID-19 among the geriatric age group in African countries: protocol for a systematic review and

Degena Bahrey Tadesse1, Shishay Wahdey2, Melaku Negash1

  • 1Department of Adult Health Nursing, School of Nursing, Aksum University, Aksum, Ethiopia.

Asthma Research and Practice
|October 13, 2020
PubMed

Insights

This systematic review will quantify COVID-19 outcomes in Africa's elderly population. It addresses a critical gap in understanding the pandemic's impact on this vulnerable demographic in the region.

Area of Science:

  • Public Health
  • Epidemiology
  • Geriatric Medicine

Background:

  • The COVID-19 pandemic, declared a global emergency by WHO, has infected millions worldwide.
  • Limited data exists on COVID-19 outcomes specifically within Africa's geriatric population.
  • This study addresses the urgent need for evidence on elderly COVID-19 outcomes in Africa.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis on the outcomes of COVID-19 among the geriatric age group in Africa.
  • To provide a comprehensive understanding of the pandemic's impact on elderly individuals in the African continent.
  • To establish a guideline for future research in this area.

Main Methods:

  • Inclusion of published and unpublished studies in any language from March to August 2020.
  • Systematic search of multiple databases including PubMed, Google Scholar, EMBASE, and WHO COVID-19 database.
  • Data extraction, risk of bias assessment, and meta-analysis using a random-effects model, adhering to PRISMA-P guidelines.

Main Results:

  • The review protocol aims to quantify the proportion of adverse outcomes in geriatric patients with COVID-19 in Africa.
  • Subgroup analyses will be performed to address heterogeneity.
  • Publication bias will be assessed using Egger's test and funnel plots.

Conclusions:

  • This systematic review and meta-analysis protocol is expected to yield crucial data on COVID-19 outcomes in Africa's elderly.
  • Findings will inform public health strategies and clinical management for geriatric patients in the region.
  • The study contributes to global understanding of COVID-19's differential impact across demographics and continents.
Abstract

Keywords:
AfricaCOVID-19GeriatricOutcome

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

967

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
110
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
110
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
92
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
128
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
156
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
127